Korean J Med.  2007 Sep;73(3):235-236.

HIV drug resistance in treatment-naive HIV patients

Affiliations
  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Abstract

Antiretroviral therapy for treatment of human immunodeficiency virus type 1 (HIV-1) infection has improved steadily since the introduction of combination therapy in 1996. With the advancement of antiretroviral therapy, the mortality of AIDS patients has markedly improved. However, drug resistance has been emerging as a major problem in HIV treatment. Several studies reported that the prevalence of transmitted resistant virus involving antiretroviral-naive people in developed countries was around 10%. Primary drug resistance is rare in HIV-1 infected patients in Korea. A cohort study is need to monitor resistant HIV-1 among newly infected individuals.

Keyword

HIV-1 infection; Antiretroviral therapy; Antiretroviral drug resistance

MeSH Terms

Cohort Studies
Developed Countries
Drug Resistance*
HIV*
HIV-1
Humans
Korea
Mortality
Prevalence
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error